← All trials
NCT05539989
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 31, 2023
- Primary completion
- Sep 30, 2025
- Completion date
- Sep 30, 2025
- First posted
- Sep 14, 2022
- Last posted
- Sep 16, 2022
- Enrollment
- 480
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- National Institute of Child Health and Human Development (NICHD)Lead sponsor
- National Institutes of Health (NIH)Collaborator
- National Institute of Allergy and Infectious Diseases (NIAID)Collaborator
- National Institute of Mental Health (NIMH)Collaborator
- Emory UniversityStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.